Literature DB >> 21289613

Osteoporosis in 2010: building bones and (safely) preventing breaks.

Elaine Dennison1, Cyrus Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21289613     DOI： 10.1038/nrrheum.2010.227

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Familial resemblance and diversity in bone mass and strength in the population are established during the first year of postnatal life.

Authors:  Qingju Wang; Markku Alén; Arja Lyytikäinen; Leiting Xu; Fran A Tylavsky; Urho M Kujala; Heikki Kröger; Ego Seeman; Sulin Cheng
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

2.  Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.

Authors:  Desmond Padhi; Graham Jang; Brian Stouch; Liang Fang; Edward Posvar
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

Review 3.  Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis.

Authors:  J Baird; M A Kurshid; M Kim; N Harvey; E Dennison; C Cooper
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

4.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

Review 5.  Adverse effects of bisphosphonates.

Authors:  Bo Abrahamsen
Journal:  Calcif Tissue Int       Date:  2010-04-21       Impact factor: 4.333

6.  Exposure to oral bisphosphonates and risk of esophageal cancer.

Authors:  Chris R Cardwell; Christian C Abnet; Marie M Cantwell; Liam J Murray
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

7.  Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.

Authors:  Jane Green; Gabriela Czanner; Gillian Reeves; Joanna Watson; Lesley Wise; Valerie Beral
Journal:  BMJ       Date:  2010-09-01

8.  Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

Authors:  Joanna Watson; Lesley Wise; Jane Green
Journal:  Eur J Clin Pharmacol       Date:  2007-06-28       Impact factor: 2.953

9.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741
  9 in total
  1 in total

1.  Small leucine rich proteoglycans, a novel link to osteoclastogenesis.

Authors:  Vardit Kram; Tina M Kilts; Nisan Bhattacharyya; Li Li; Marian F Young
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.